Moleculin Biotech prices offering with warrants for 37,130,001 shares at $0.75 exercise price

Reuters2026/07/31 14:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Moleculin Biotech priced a $9.3 million best-efforts public offering bundled with Common Warrants to buy up to 37,130,001 shares.
Common Warrants become immediately exercisable at USD 0.75 per share, expiring five years from the initial exercise date.
Offering includes 12,376,667 common shares or pre-funded warrants at a combined price of USD 0.75 with associated warrants.
Net proceeds earmarked to advance Annamycin clinical development, support working capital; closing expected around Aug. 3, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607311012PRIMZONEFULLFEED9801649) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Moleculin Biotech prices offering with warrants for 37,130,001 shares at $0.75 exercise price

You may also like

Crypto prices